产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
497061-48-0 |
|---|---|
中文名称 |
3-氨基-N-(2-溴-4,6-二氟苯基)-6,7-二氢-5H-环戊二烯并[b]噻吩并[3,2-e]吡啶-2-甲酰胺 |
英文名称 |
3-Amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-5H-cyclopenta[b]thieno[3,2-e]pyridine-2-carboxamide |
别名 |
3-amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-5H-cyclopenta[b]thieno[3,2-e]pyridine-2-carboxamide;DC_AC50 (DC-AC50;DC_AC50;5H-Cyclopenta[b]thieno[3,2-e]pyridine-2-carboxamide, 3-amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-;DC_AC50 >=98% (HPLC);DC_AC-50,resistance,DC_AC50,osteosarcoma,CCS,copper,chaperones,Atox1,inhibit,Apoptosis,Chemotherapy,Inhibitor;DC_AC50, 10 mM in DMSO |
标准英文名 |
3-amino-N-(2-bromo-4,6-difluorophenyl)-6,7-dihydro-5H-cyclopenta[b]thieno[3,2-e]pyridine-2-carboxamide |
MDL No. |
MFCD00058097 |
分子式 |
C17H12BrF2N3OS |
分子量 |
424.27 |
精确分子量 |
422.99 |
SMILES |
NC1=C(SC2=NC3=C(C=C21)CCC3)C(NC4=C(C=C(C=C4Br)F)F)=O |
标准SMILES |
NC1=C(SC2=NC3CCCC=3C=C21)C(=O)NC1C(Br)=CC(F)=CC=1F |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
DFNOJNBNTVQPCA-UHFFFAOYSA-N |
危险类别(旧) |
H315,H319,H335 |
存储要求 |
Keep in dark place, Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|